CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Novartis AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Novartis AG
Lichtstrasse 35
Phone: +41 613241111p:+41 613241111 BASEL, 4056  Switzerland Ticker: NOVNNOVN
Business Summary
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYesYes

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
3841 Surgical and medical instruments and apparatus
3851 Ophthalmic goods
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board JoergReinhardt 68 8/1/2013 2/1/2010
Chief Executive Officer, Member of the Executive Committee VasantNarasimhan 48 2/1/2018 2/1/2016
Independent Non-Executive Vice Chairman of the Board Simon E.Moroney 65 3/4/2022 2/28/2020
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Novartis Finance B.V. Netherlands
Novartis Overseas Finance Ltd. Switzerland
NOVARTIS FARMACEUTICA,S.A. GRAN VIA CORTS CATALANES, 764 BARCELONA ES
35 additional Subsidiary records available in full report.

Business Names
Business Name
0K9E
0QLR
Abadia Retuerta S.A.
154 additional Business Names available in full report.

General Information
Number of Employees: 76,057 (As of 12/31/2023)
Outstanding Shares: 1,999,270,033 (As of 9/30/2024)
Shareholders: 183,265
Stock Exchange: SWF
Federal Tax Id: 000004600
Fax Number: +41 613247826


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024